XTL Biopharmaceuticals XTLB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 8.10 | 5 | -4.57 | 0 | -2.86 | 9 |
| 2024Q3 | 9.62 | 6 | -13.91 | -1 | -9.47 | 9 |
| 2024Q2 | 9.72 | 2 | -28.51 | -1 | -26.44 | 2 |
| 2024Q1 | 11.24 | 3 | 19.70 | 0 | 18.12 | 3 |
| 2023Q4 | 4.04 | 2 | -12.03 | 0 | -11.16 | 2 |
| 2023Q3 | 3.59 | 3 | -8.24 | 0 | -7.76 | 3 |
| 2023Q2 | 4.00 | 3 | -12.55 | 0 | -11.74 | 3 |
| 2023Q1 | 5.24 | 3 | -25.96 | -1 | -24.48 | 3 |
| 2022Q4 | 4.84 | 4 | -17.11 | -1 | -16.47 | 4 |
| 2022Q3 | 4.44 | 5 | -15.93 | -1 | -15.41 | 5 |
| 2022Q2 | 6.08 | 6 | -5.00 | 0 | -4.60 | 6 |
| 2022Q1 | 9.48 | 6 | 9.05 | 1 | 7.64 | 7 |
| 2021Q4 | 11.08 | 5 | 49.81 | 2 | 31.10 | 7 |
| 2021Q3 | 17.52 | 3 | -16.04 | -1 | -7.39 | 7 |
| 2021Q2 | 15.96 | 3 | -22.62 | -1 | -12.13 | 7 |
| 2021Q1 | 13.32 | 4 | 5.39 | 0 | 4.14 | 7 |
| 2020Q4 | 12.12 | 6 | 3.34 | 0 | 3.23 | 7 |
| 2020Q3 | 7.60 | 6 | -9.35 | -1 | -9.08 | 6 |
| 2020Q2 | 6.36 | 7 | -13.69 | -1 | -13.26 | 7 |
| 2020Q1 | 4.70 | 7 | 0 | 7 |